Circulation Research, Vol 44, 16-23, Copyright © 1979 by American Heart Association
ARTICLES |
The effects of nifedipine on acute experimental myocardial ischemia and infarction in dogs
AP Selwyn, E Welman, K Fox, P Horlock, T Pratt and M Klein
We studied 25 anesthetized and thoracotamized dogs before and during 5 hours of acute regional myocardial ischemia. Krypton-81m (81mKr) was infused constantly into the aortic sinuses. The myocardial equilibrium of this tracer was used to image and assess the distribution of regional myocardial perfusion using a gamma camera and digital computer. The epicardial ECG was recorded, S-T segment elevation and the loss of R and appearance of Q waves were measured, and the plasma activity of creatine kinase (CK) was determined in aortic and coronary venous blood throughout these experiments. Ten dogs underwent left anterior descending coronary artery (LAD) narrowing for 5 hours and received no drugs. Five dogs received nifedipine 13 microgram/kg, and another five received 1.0 microgram/kg intravenously 30 minutes after LAD narrowing. Those dogs receiving nifedipine, 13 microgram/kg, showed a 30% fall in aortic pressure, a 12% rise in heart rate, and an extension of regional ischemia. The ECG showed an extension of infarct size, and CK release into the coronary vein appeared earlier than in the controls. Dogs receiving nifedipine, 1 microgram/kg, showed a 12% fall in blood pressure, no rise in heart rate, an improvement in regional perfusion, and ECG signs that suggested limitation of infarct size. There also was delayed release of coronary venous CK. The effects of nifedipine on the natural history of regional myocardial perfusion, the electrocardiogram, and enzyme release from the heart were dose related and cannot be generalized. These observations warrant further clinical investigation to improve the use of this agent in man.
This article has been cited by other articles:
 |
|
 |
|
  F. Dagenais, R. Cartier, C. Hollmann, and J. Buluran Calcium-Channel Blockers Preserve Coronary Endothelial Reactivity After Ischemia-Reperfusion Ann. Thorac. Surg., April 1, 1997; 63(4): 1050 - 1056. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. H. Opie and F. H. Messerli Nifedipine and Mortality : Grave Defects in the Dossier Circulation, September 1, 1995; 92(5): 1068 - 1073. [Full Text]
|
|
|
|
 |
|
 U. Goldbourt, S. Behar, H. Reicher-Reiss, M. Zion, L. Mandelzweig, and E. Kaplinsky Early Administration of Nifedipine in Suspected Acute Myocardial Infarction: The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study Arch Intern Med, February 8, 1993; 153(3): 345 - 353. [Abstract] [PDF]
|
|
|
|
|
|
A. E. Skolnick and W. H. Frishman Calcium Channel Blockers in Myocardial Infarction Arch Intern Med, July 1, 1989; 149(7): 1669 - 1677. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Noera, C. Massini, R. Lodi, and G. Baggio Normothermic blood cardioplegia reperfusion plus nifedipine after cardioplegic arrest: experimental study with a new delivery set Perfusion, July 1, 1987; 2(3): 185 - 194. [Abstract] [PDF]
|
|
|
|
 |
|
 Drugs Five Years Later: Nifedipine in Myocardial Ischemia, Systemic Hypertension, and Other Cardiovascular Disorders Ann Intern Med, November 1, 1986; 105(5): 714 - 729. [Abstract] [PDF]
|
|
|
|
 |
|
 M. D. Winniford, J. T. Willerson, and L. D. Hillis Calcium Antagonists in the Treatment of Individuals with Ischemic Heart Disease Angiology, August 1, 1982; 33(8): 522 - 539. [Abstract] [PDF]
|
|
|
|
|
|
P. H. STONE, E. M. ANTMAN, J. E. MULLER, and E. BRAUNWALD Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part II: Hemodynamic Effects and Clinical Applications Ann Intern Med, December 1, 1980; 93(6): 886 - 904. [Abstract] [PDF]
|
|